tiprankstipranks
Advertisement
Advertisement
SNDX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsSNDX Upcoming Earnings Report: What to Expect?
14d ago
Syndax: Expanding Pipeline and Upcoming Axatilimab IPF Data Support Buy Rating and $29 Price Target Upside
Premium
Ratings
Syndax: Expanding Pipeline and Upcoming Axatilimab IPF Data Support Buy Rating and $29 Price Target Upside
1M ago
Syndax: Strengthening Pipeline and R&D Outlook Support Buy Rating and Unchanged $34 Price Target
Premium
Ratings
Syndax: Strengthening Pipeline and R&D Outlook Support Buy Rating and Unchanged $34 Price Target
1M ago
Syndax Buy Rating Reiterated as Revuforj Data Strengthens AML Profile; $40 Price Target Maintained
PremiumRatingsSyndax Buy Rating Reiterated as Revuforj Data Strengthens AML Profile; $40 Price Target Maintained
2M ago
Syndax presents data from SAVE trial at EHA
Premium
The Fly
Syndax presents data from SAVE trial at EHA
2M ago
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement
Premium
Company Announcements
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement
2M ago
Syndax price target lowered to $37 from $38 at UBS
PremiumThe FlySyndax price target lowered to $37 from $38 at UBS
3M ago
Syndax reports 12 Revuforj abstracts accepted for EHA
Premium
The Fly
Syndax reports 12 Revuforj abstracts accepted for EHA
3M ago
Syndax price target raised to $46 from $45 at Stifel
Premium
The Fly
Syndax price target raised to $46 from $45 at Stifel
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100